Not currently recruiting at UCSD
COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Saima Aslam, MBBS
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Saima Aslam, MBBS
Clinical Professor, Medicine, Vc-health Sciences-schools. Authored (or co-authored) 83 research publications
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- National Institute of Allergy and Infectious Diseases (NIAID) Division of Allergy, Immunology, and Transplantation (DAIT)
- ID
- NCT05518487
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 80 study participants
- Last Updated